Structural basis for the interaction of the free SH2 domain EAT‐2 with SLAM receptors in hematopoietic cells

The T and natural killer (NK) cell‐specific gene SAP (SH2D1A) encodes a ‘free SH2 domain’ that binds a specific tyrosine motif in the cytoplasmic tail of SLAM (CD150) and related cell surface proteins. Mutations in SH2D1A cause the X‐linked lymphoproliferative disease, a primary immunodeficiency. Here we report that a second gene encoding a free SH2 domain, EAT‐2, is expressed in macrophages and B lympho cytes. The EAT‐2 structure in complex with a phosphotyrosine peptide containing a sequence motif with Tyr281 of the cytoplasmic tail of CD150 is very similar to the structure of SH2D1A complexed with the same peptide. This explains the high affinity of EAT‐2 for the pTyr motif in the cytoplasmic tail of CD150 but, unlike SH2D1A, EAT‐2 does not bind to non‐phosphorylated CD150. EAT‐2 binds to the phosphorylated receptors CD84, CD150, CD229 and CD244, and acts as a natural inhibitor, which interferes with the recruitment of the tyrosine phosphatase SHP‐2. We conclude that EAT‐2 plays a role in controlling signal transduction through at least four receptors expressed on the surface of professional antigen‐presenting cells.

[1]  G. Vawter,et al.  X-LINKED RECESSIVE PROGRESSIVE COMBINED VARIABLE IMMUNODEFICIENCY (DUNCAN'S DISEASE) , 1975, The Lancet.

[2]  J. Trapani,et al.  Isolation and characterization of cDNA clones for mouse Ly-9. , 1992, Journal of immunology.

[3]  C. Terhorst,et al.  Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. , 2002, Blood.

[4]  C Terhorst,et al.  Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. , 1999, Molecular cell.

[5]  J. Sullivan.  The abnormal gene in X-linked lymphoproliferative syndrome. , 1999, Current opinion in immunology.

[6]  T. Pawson,et al.  Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A , 1999, Current Biology.

[7]  D I Stuart,et al.  Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. , 2000, The Journal of biological chemistry.

[8]  C. Terhorst,et al.  The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus. , 2000, Current opinion in immunology.

[9]  M. Colonna,et al.  2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. , 2000, Human immunology.

[10]  A. Coyle,et al.  Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease , 2000, Immunogenetics.

[11]  A. Neil Barclay,et al.  2B4, the Natural Killer and T Cell Immunoglobulin Superfamily Surface Protein, Is a Ligand for CD48 , 1998, The Journal of experimental medicine.

[12]  S. Grzesiek,et al.  NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.

[13]  P. Borrow,et al.  SAP controls T cell responses to virus and terminal differentiation of TH2 cells , 2001, Nature Immunology.

[14]  L. Szekely,et al.  SH2D1A and slam protein expression in human lymphocytes and derived cell lines , 2000 .

[15]  Jack R. Davis,et al.  Characterization of SH2D1A Missense Mutations Identified in X-linked Lymphoproliferative Disease Patients* , 2001, The Journal of Biological Chemistry.

[16]  D Cowburn,et al.  Modular peptide recognition domains in eukaryotic signaling. , 1997, Annual review of biophysics and biomolecular structure.

[17]  B. Cocks,et al.  A novel receptor involved in T-cell activation , 1995, Nature.

[18]  L. Notarangelo,et al.  X-Linked Lymphoproliferative Disease 2b4 Molecules Displaying Inhibitory Rather than Activating Function Are Responsible for the Inability of Natural Killer Cells to Kill Epstein-Barr Virus–Infected Cells , 2000 .

[19]  K. Clausen,et al.  X-linked lymphoproliferative syndrome registry report. , 1980, The Journal of pediatrics.

[20]  P. Engel,et al.  Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. , 2001, Blood.

[21]  J. Schatzle,et al.  Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. , 2000, International immunology.

[22]  S. Tangye,et al.  Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. , 1999, Journal of immunology.

[23]  P. Pizcueta,et al.  CD84 leukocyte antigen is a new member of the Ig superfamily. , 1997, Blood.

[24]  B. Cocks,et al.  Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B Lymphocytes , 1997, The Journal of experimental medicine.

[25]  D. Purtilo,et al.  Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. , 1980, Science.

[26]  Jack R. Davis,et al.  Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene , 1998, Nature Genetics.

[27]  J. Kuriyan,et al.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms , 1993, Cell.

[28]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[29]  C. Denny,et al.  EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. , 1996, Oncogene.

[30]  V S Lamzin,et al.  Automated refinement for protein crystallography. , 1997, Methods in enzymology.

[31]  E. Lacy,et al.  A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Friedrich,et al.  Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). , 1999, Human molecular genetics.

[33]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[34]  P. Engel,et al.  X-linked lymphoproliferative disease: a progressive immunodeficiency. , 2001, Annual review of immunology.

[35]  E. Kieff,et al.  The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Pabst,et al.  Cutting Edge: Defective NK Cell Activation in X-Linked Lymphoproliferative Disease1 , 2000, The Journal of Immunology.

[37]  G. Klein,et al.  Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. , 2000, Blood.

[38]  T. Pawson,et al.  Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product , 2001, Nature Immunology.

[39]  K. Nichols,et al.  Diagnosis of X‐linked lymphoproliferative disease by analysis of SLAM‐associated protein expression , 2000, European journal of immunology.

[40]  O. Silander,et al.  Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. , 2001, Blood.

[41]  W. Dandliker,et al.  Equilibrium and kinetic inhibition assays based upon fluorescence polarization. , 1981, Methods in enzymology.

[42]  L. Lanier.  NK cell receptors. , 1998, Annual review of immunology.

[43]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[44]  E. Snyder,et al.  Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Jack R. Davis,et al.  X-Linked Lymphoproliferative Disease: Twenty-Five Years after the Discovery , 1995, Pediatric Research.

[46]  T A Jones,et al.  Electron-density map interpretation. , 1997, Methods in enzymology.

[47]  P. Engel,et al.  CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells , 2001, Immunogenetics.

[48]  S. P. Sidorenko,et al.  Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. , 1993, Journal of immunology.

[49]  D. Allen,et al.  The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM , 1998, Nature.

[50]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.